China’s mRNA Vaccine Developer Abogen Raises $3 Million
What’s new: Chinese mRNA vaccine developer Suzhou Abogen Biosciences raised $3 million following a $7.2 million C round of financing in August.
The fundraising was led by Softbank Vision Fund and existing investor 5Y Capital. Other investors include Chimera Abu Dhabi, Oriental Fortune Capital, Jinyi Capital, New Frontier Corp., IMO Ventures and South Korean financial services group Mirae Asset Financial Group.
- MOST POPULAR